Analysis for IEX
- 📈 Growth — 22/30
- 💰 Profitability — 15/20
- 🏦 Financial Health — 18/20
- 💵 Valuation — 14/20
- ⚠️ Risk — 5/10
Summary:
📈 Growth & Financial Trajectory
Over eight trailing quarters (2024 Q2 to 2026 Q2), the top line advanced from $807.2M to $920.6M, up about 14%. Net income rose modestly from $141.2M to $143.4M (roughly 1.6%), signaling a resilient earnings base despite volatility. Gross margin expanded from about 45.4% to 46.3%, while operating margin softened from about 22.6% to 21.7%, implying tighter operating leverage as input costs and SG&A rose in certain periods.
💰 Margins & Cash Flow
Gross leverage remained stable; strong gross margins support profitability, though operating margins fluctuated. Operating cash flow was healthy across periods, with Net Cash Flow From Operating Activities generally positive (peaking near $170–200M in several quarters) and occasional cash flow swings from financing activities. Free cash flow remained robust enough to fund financing needs while maintaining liquidity.
🛡️ Balance Sheet & Liquidity
Total assets run around $6.9–7.0B with equity of about $3.8–4.0B and long-term debt typically around $1.3–1.9B. Current assets consistently exceed current liabilities, producing a healthy Current Ratio ~3.0x. Leverage is manageable; liquidity cushions are solid.
⚠️ Key Drivers & Risks
- Drivers: steady demand in industrial components, diversified end-markets, and ongoing capex in manufacturing.
- Risks: cyclicality in industrials, commodity/currency sensitivity, and potential margin compression if input costs spike.